MT-1 research continues to inform our understanding of melanocortin signaling in laboratory and clinical research settings
This product may not be used as a pharmaceutical or veterinary drug, agricultural product, or food additive.
Additionally, we are grateful for the collaboration of the avexitide clinical trial investigators. Post-bariatric hypoglycemia places a tremendous burden on individuals, with frequent and unpredictable hypoglycemic events that can cause severe symptoms such as impaired cognition, loss of consciousness, and seizures, said Endocrine Society member Marilyn Tan, MD , principal investigator of the LUCIDITY clinical trial and clinical associate professor of medicine at Stanford University School of Medicine
The results were highly encouraging, with participants experiencing significant weight loss
GLP-1 receptor agonists slow down how quickly your stomach empties